Triumeq is a single-tablet regimen for patients with HIV infection comprising 
dolutegravir, abacavir and lamivudine. Overdoses with Triumeq have not been 
reported previously. We present a case of a 26-year-old man who presented to our 
hospital after intentionally ingesting 30 tablets of Triumeq. An intoxication 
with Triumeq can lead to several side effects. An overdose of abacavir and 
lamivudine can cause mitochondrial toxicity and lactic acidosis. An intoxication 
with dolutegravir appears to be relatively harmless. As Triumeq will be used on 
a regular basis as treatment for patients with HIV-1 infection, these 
intoxications are expected to be encountered more often.